Here's what to expect: Typical Semaglutide Titration: Weeks 1-4: 0.25 mg weekly (lowest dose) Weeks 5-8: 0.5 mg weekly Weeks 9-12: 1.0 mg weekly Weeks 13-16: 1.7 mg weekly Week 17+: 2.4 mg weekly (maintenance) Typical Tirzepatide Titration: Weeks 1-4: 2.5 mg weekly Weeks 5-8: 5 mg weekly Weeks 9-12: 7.5 mg weekly Weeks 13-16: 10 mg weekly Weeks 17-20: 12.5 mg weekly Week 21+: 15 mg weekly (maintenance) You'll have a nurse check-in at each dose adjustment to monitor tolerability, appetite suppression, weight change, and side effects
Before drawing the medication, wipe the rubber cap with an alcohol swab
Patients may report that food simply tastes less appealing or that they experience diminished pleasure from eating
Bibcode:1995FEBSL.373..182G
The clinical trial sponsors include foreign giants such as Eli Lilly, AstraZeneca, and MSD, as well as Chinese domestic companies, e.g., Hengrui Pharmaceuticals, Gan & Lee, and Tonghua Dongbao